Wordt geladen...
Pharmacokinetics and pharmacodynamics of a fixed-dose combination of gemigliptin/metformin sustained release 25/500 mg compared to the loose combination in healthy male subjects
A fixed-dose combination (FDC) of gemigliptin/metformin can improve the medication adherence in patients with type 2 diabetes mellitus (T2DM). In this study, the pharmacokinetic (PK) and pharmacodynamic (PD) profiles of gemigliptin and metformin were compared between FDC and the corresponding loose...
Bewaard in:
| Gepubliceerd in: | Transl Clin Pharmacol |
|---|---|
| Hoofdauteurs: | , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Korean Society for Clinical Pharmacology and Therapeutics
2020
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7136079/ https://ncbi.nlm.nih.gov/pubmed/32274380 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12793/tcp.2020.28.e2 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|